4593 — Healios KK Income Statement
0.000.00%
Last trade - 00:00
- ¥13bn
- ¥15bn
- ¥121m
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 89 | 27 | 41 | 90 | 121 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 108 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,395 | 4,847 | 4,024 | 5,139 | 4,042 |
Operating Profit | -4,306 | -4,820 | -3,983 | -5,049 | -3,921 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4,559 | -5,378 | -4,462 | -5,330 | -3,626 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4,807 | -5,513 | -4,912 | -5,170 | -3,813 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -4,806 | -5,512 | -4,911 | -5,169 | -3,823 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4,806 | -5,512 | -4,910 | -5,169 | -3,823 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -95.7 | -99.1 | -111 | -92.1 | -51 |
Dividends per Share |